Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation

Background/AimsThe dose of mycophenolate mofetil (MMF) has been reduced in Asia due to side effects associated with the conventional fixed dose of 2-3 g/day. We aimed to determine the pharmacokinetics of a reduced dose of MMF and to validate its feasibility in combination with tacrolimus in living-d...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Hyeyoung Kim, Nam-Joon Yi, Juyeun Lee, Joohyun Kim, Mi-Ra Moon, Jaehong Jeong, Jeong-Moo Lee, Tae Suk You, Suk-Won Suh, Min-Su Park, YoungRok Choi, Geun Hong, Hae Won Lee, Kwang-Woong Lee, Kyung-Suk Suh
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Korean Association for the Study of the Liver 2014-09-01
Rangatū:	Clinical and Molecular Hepatology
Ngā marau:	Area under the curve Mycophenolate mofeti Mycophenolic acid Therapeutic drug monitoring Liver transplant
Urunga tuihono:	http://e-cmh.org/upload/pdf/cmh-20-291.pdf
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!